{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:04:54Z","timestamp":1747181094399,"version":"3.40.5"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,28]]},"abstract":"<jats:p>To determine factors associated with lateralization in primary aldosteronism (PA). The clinical data for PA patients hospitalized at the First Affiliated Hospital of Guangxi Medical University from October 2016 to March 2021 were included in this study. They were classified according to results derived from computed tomography (CT): bilaterally normal nodules (no typical nodules were found in either adrenal glands, only changes in unilateral adrenal hyperplasia thickening or bilateral adrenal hyperplasia thickening), unilateral nodules (typical nodule appears in unilateral adrenal gland, and there are no abnormalities in the contralateral adrenal gland or only thickening of unilateral adrenal hyperplasia) and bilateral nodules (typical nodule like changes in bilateral adrenal glands). Multivariate logistic regression and receiver operating characteristic (ROC) were used to analyze the factors associated with lateralization of PA and consistencies between adrenal CT images and adrenal venous sampling (AVS) results. A total of 269 patients with PA were recruited, with an average age of 46 years and 112 cases had typical nodules. Results from CT scans revealed that there were 49 bilateral normal cases, 177 cases were unilateral abnormal and 43 cases were bilateral abnormal. In all of the PA patients, multifactorial logistic regression analysis showed that the maximum systolic blood pressure (OR = 1.03, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), history of stroke (OR = 2.61, <jats:italic toggle=\"yes\">P<\/jats:italic> = .028), and typical nodules (OR = 1.9, <jats:italic toggle=\"yes\">P<\/jats:italic> = .017) were all relevant factors in unilateral primary aldosteronism (UPA). In the unilateral nodule group, multivariate logistic regression analysis suggested that maximum systolic blood pressure (OR = 1.03, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001) and typical nodules (OR = 2.37, <jats:italic toggle=\"yes\">P<\/jats:italic> = .008) were the related factors for UPA. However, the consistency between adrenal CT and AVS was only 40.68%, while maximum systolic blood pressure (OR = 1.02, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001) and plasma aldosterone renin ratio (OR = 1.001, <jats:italic toggle=\"yes\">P<\/jats:italic> = .027) were the relevant consistent factors between AVS and CT results. Maximum systolic blood pressure, typical nodules, and history of stroke are important factors to consider when screening for UPA. It is recommended to combine medical history and imaging findings when looking at different subgroups before a clinical decision is made. Patients with PA in the absence of lesions or bilateral lesions on CT should be diagnosed by AVS as far as possible.<\/jats:p>","DOI":"10.1097\/md.0000000000031313","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T03:05:58Z","timestamp":1667185558000},"page":"e31313","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Screening for unilateral aldosteronism should be combined with the maximum systolic blood pressure, history of stroke and typical nodules"],"prefix":"10.1097","volume":"101","author":[{"given":"Yumin","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kequan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aixin","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-6371","authenticated-orcid":false,"given":"Jiangnan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-0029-1243619","article-title":"Progress in primary aldosteronism: present challenges and perspectives.","volume":"42","author":"Gomez-Sanchez","year":"2010","journal-title":"Horm Metab Res"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline.","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"101375","DOI":"10.1016\/j.beem.2020.101375","article-title":"Old and new genes in primary aldosteronism.","volume":"34","author":"Boulkroun","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MED.0000000000000409","article-title":"Overview of aldosterone-related genetic syndromes and recent advances.","volume":"25","author":"Zennaro","year":"2018","journal-title":"Curr Opin Endocrinol Diabet Obes"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tem.2021.10.002","article-title":"Pathophysiology and histopathology of primary aldosteronism.","volume":"33","author":"Williams","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"927669","DOI":"10.3389\/fendo.2022.927669","article-title":"Pathogenesis of primary aldosteronism: impact on clinical outcome.","volume":"13","author":"Santana","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1507\/endocrj.EJ20-0478","article-title":"The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.","volume":"67","author":"Oki","year":"2020","journal-title":"Endocr J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/HYPERTENSIONAHA.106.086116","article-title":"Is there an unrecognized epidemic of primary aldosteronism? Pro.","volume":"50","author":"Calhoun","year":"2007","journal-title":"Hypertension"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/HJH.0000000000002520","article-title":"Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jcem-58-5-783","article-title":"Primary adrenal hyperplasia: a new subset of primary hyperaldosteronism.","volume":"58","author":"Banks","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome.","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R14-20250504","first-page":"493","article-title":"Clinical study of a new digitalic drug in 50 patients: deacetyl lanatoside C.","volume":"21","author":"Arnaud","year":"1972","journal-title":"Ann Cardiol Ang\u00e9iol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1373\/clinchem.2007.092080","article-title":"Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism.","volume":"53","author":"Giulio","year":"2007","journal-title":"Clin Chem"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1507\/endocrj.K07E-164","article-title":"Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism.","volume":"55","author":"Minami","year":"2008","journal-title":"Endocr J"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism.","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","article-title":"Development and validation of subtype prediction scores for the workup of primary aldosteronism.","volume":"36","author":"Kobayashi","year":"2018","journal-title":"J Hypertens"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","article-title":"The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma.","volume":"247","author":"Zarnegar","year":"2008","journal-title":"Ann Surg"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan.","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur Heart J"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"116774","DOI":"10.1016\/j.jns.2020.116774","article-title":"Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics.","volume":"413","author":"Tang","year":"2020","journal-title":"J Neurol Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","article-title":"Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats.","volume":"43","author":"Nishiyama","year":"2004","journal-title":"Hypertension"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment.","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1 Pt 2","key":"R27-20250504","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism.","volume":"97","author":"Kupers","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14310\/horm.2002.1342","article-title":"Adrenal venous sampling as a diagnostic procedure for primary hyperaldosteronism: experience from a tertiary referral centre.","volume":"11","author":"Salem","year":"2012","journal-title":"Hormones (Athens)"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism.","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/SLA.0000000000003200","article-title":"The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism.","volume":"272","author":"Burrello","year":"2020","journal-title":"Ann Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:34:29Z","timestamp":1746333269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":31,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031313","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}